ITG Brands Appeals FDAs Marketing Denial Order
The tobacco company says myblu ENDs products subject to the MDO can stay on the retail market pending appeal.
Source: pressreleasepoint.com
Stay updated with breaking news from Device Kit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The tobacco company says myblu ENDs products subject to the MDO can stay on the retail market pending appeal.
ALEXANDRIA, Va.—The U.S. Food and Drug Administration (FDA) has issued marketing denial orders (MDOs) to Fontem U.S. for several myblu electronic nicotine delivery system (ENDS) products, according to a news release.